More than 5,000 test subjects aged 50-74 years underwent a one-sample FIT screening, while another 3,197 test subjects underwent a two-sample FIT screening. The two-sample group collected fecal samples on two consecutive days. If any subjects tested positive with at least one sample, they were referred for colonoscopy.
Results showed subject attendance was 61.5 percent and 61.3 percent in the one-sample and two-sample group, respectively. Further, 8.1 percent of subjects in the one-sample group tested positive. By comparison, 12.8 percent of subjects in the two-sample group received one positive test outcomes and 5 percent had two positive test outcomes. Similarly, advanced neoplasia detection rates were 3.1 percent for the one-sample group, compared to 4.1 percent of patients with one positive outcome and 3.7 percent of patients with two positive outcomes in the two-sample group.
Read the study about two samples in fecal immunochemical testing.
Read other coverage about colorectal cancer screening:
– Reimbursement for Virtual Colonoscopy May Vary By Region
– Colorectal Cancer Experts Hold Capitol Hill Briefing to Push CRC Screening Program
– Letter, Phone Call Improves CRC Screening Adherence, Especially Among Minorities
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.